Fund Tracker India by Ishaan Dungarwal
Guide
SchemeNippon India Mutual FundOther Scheme - Other ETFsAMFI code 149008

Nippon India Nifty Pharma ETF

Holdings for Oct 2026, changes against Sep 2026, from Nippon India Mutual Fund's monthly file.

Nippon India Nifty Pharma ETF portfolio holdings, Oct 2026: 20 stocks, ₹1,756 cr in listed equity, from Nippon India Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Jitendra Tolani

Benchmark: Nifty Pharma TRI · Riskometer: Very High · Allotted 2 Jul 2021

Source: AMFI scheme summary document

NAV

Nippon India Nifty Pharma ETF - Direct Plan

Source: AMFI

₹29.186320 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹1,700 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 0.26 %, regular 0.32 % (213 schemes)

Of this, the base expense ratio, the part SEBI caps: direct 0.18 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 20 Nov 2026. Source: AMFI · Glossary: TER

Direct 0.23 %a year, as of 20 Nov 2026
Equity held

20 stocks, Oct 2026.

Source: Nippon India Mutual Fund monthly portfolio

₹1,756 cr20 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 78.6%.

100.0%top 10 stocks 78.6%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹1,034 cr, 20 stocks, NAV ₹23.56Dec 2025: equity held ₹1,026 cr, 20 stocks, NAV ₹23.27Jan 2026: equity held ₹1,007 cr, 20 stocks, NAV ₹22.24Feb 2026: equity held ₹1,058 cr, 20 stocks, NAV ₹23.55Mar 2026: equity held ₹1,247 cr, 20 stocks, NAV ₹22.81Apr 2026: equity held ₹1,356 cr, 20 stocks, NAV ₹23.87May 2026: equity held ₹1,570 cr, 20 stocks, NAV ₹24.97Jun 2026: equity held ₹1,621 cr, 20 stocks, NAV ₹26.00Jul 2026: equity held ₹1,688 cr, 20 stocks, NAV ₹27.28Aug 2026: equity held ₹1,759 cr, 20 stocks, NAV ₹27.96Sep 2026: equity held ₹1,736 cr, 20 stocks, NAV ₹27.18Oct 2026: equity held ₹1,756 cr, 20 stocks, NAV ₹27.89
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▲ +4.0%▲ +2.2%
6 monthsApr 2026▲ +29.5%▲ +16.8%
12 monthsOct 2025▲ +71.7%▲ +22.8%
MonthEquity heldStocksNAV at month end
Nov 2025₹1,034 cr20₹23.5596
Dec 2025₹1,026 cr20₹23.2737
Jan 2026₹1,007 cr20₹22.2372
Feb 2026₹1,058 cr20₹23.5518
Mar 2026₹1,247 cr20₹22.8091
Apr 2026₹1,356 cr20₹23.8672
May 2026₹1,570 cr20₹24.9748
Jun 2026₹1,621 cr20₹25.9961
Jul 2026₹1,688 cr20₹27.2805
Aug 2026₹1,759 cr20₹27.9587
Sep 2026₹1,736 cr20₹27.1847
Oct 2026₹1,756 cr20₹27.8861
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New0
  • Added0
  • Trimmed20
  • Exited0
Stocks, by share count · Source: Nippon India Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    100.0%
  2. Rest, not itemised
    0.0%
Source: Nippon India Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
  1. 100.0%
Source: Nippon India Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Mid Cap
    47.1%
  2. Large Cap
    45.3%
  3. Small Cap
    7.6%
Source: Nippon India Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 78.6% together
  1. 18.61%
  2. 12.28%
  3. 9.26%
  4. 8.15%
  5. 7.67%
  6. 6.71%
  7. 4.83%
  8. 4.59%
  9. 3.42%
  10. 3.05%
Source: Nippon India Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

20 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
SUNPHARMA Trimmed18.64 lakh18.39 lakh−25,842−1.4%−₹4.6 cr₹327 cr
DIVISLAB Trimmed2.24 lakh2.21 lakh−3,186−1.4%−₹3.1 cr₹216 cr
LAURUSLABS Trimmed6.86 lakh6.76 lakh−9,558−1.4%−₹2.3 cr₹163 cr
DRREDDY Trimmed10.74 lakh10.59 lakh−14,868−1.4%−₹2.0 cr₹143 cr
CIPLA Trimmed9.91 lakh9.77 lakh−13,688−1.4%−₹1.9 cr₹135 cr
TORNTPHARM Trimmed2.59 lakh2.56 lakh−3,540−1.4%−₹1.6 cr₹118 cr
LUPIN Trimmed4.28 lakh4.22 lakh−5,900−1.4%−₹1.2 cr₹84.8 cr
AUROPHARMA Trimmed4.87 lakh4.80 lakh−6,726−1.4%−₹1.1 cr₹80.7 cr
GLENMARK Trimmed2.65 lakh2.61 lakh−3,658−1.4%−₹0.84 cr₹60.1 cr
ZYDUSLIFE Trimmed4.36 lakh4.30 lakh−6,018−1.4%−₹0.75 cr₹53.6 cr
ALKEM Trimmed1.06 lakh1.05 lakh−1,416−1.3%−₹0.72 cr₹53.6 cr
MANKIND Trimmed2.00 lakh1.97 lakh−2,714−1.4%−₹0.68 cr₹49.1 cr
IPCALAB Trimmed2.45 lakh2.41 lakh−3,422−1.4%−₹0.66 cr₹46.5 cr
GLAND Trimmed1.40 lakh1.38 lakh−2,048−1.5%−₹0.63 cr₹42.8 cr
BIOCON Trimmed12.27 lakh12.10 lakh−16,992−1.4%−₹0.60 cr₹42.6 cr
SAILIFE Trimmed2.44 lakh2.40 lakh−3,422−1.4%−₹0.53 cr₹37.4 cr
AJANTPHARM Trimmed80,26879,248−1,020−1.3%−₹0.36 cr₹27.8 cr
WOCKPHARMA Trimmed1.45 lakh1.43 lakh−2,006−1.4%−₹0.38 cr₹27.3 cr
PPLPHARMA Trimmed10.94 lakh10.79 lakh−15,104−1.4%−₹0.36 cr₹25.8 cr
ABBOTINDIA Trimmed9,1769,058−118−1.3%−₹0.30 cr₹23.2 cr
Source: Nippon India Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (20 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
SUNPHARMASun Pharmaceutical Industries Limited Healthcare18.39 lakh₹327 cr18.61%
DIVISLABDivi's Laboratories Limited Healthcare2.21 lakh₹216 cr12.28%
LAURUSLABSLaurus Labs Limited Healthcare6.76 lakh₹163 cr9.26%
DRREDDYDr. Reddy's Laboratories Limited Healthcare10.59 lakh₹143 cr8.15%
CIPLACipla Limited Healthcare9.77 lakh₹135 cr7.67%
TORNTPHARMTorrent Pharmaceuticals Limited Healthcare2.56 lakh₹118 cr6.71%
LUPINLupin Limited Healthcare4.22 lakh₹84.8 cr4.83%
AUROPHARMAAurobindo Pharma Limited Healthcare4.80 lakh₹80.7 cr4.59%
GLENMARKGlenmark Pharmaceuticals Limited Healthcare2.61 lakh₹60.1 cr3.42%
ZYDUSLIFEZydus Lifesciences Limited Healthcare4.30 lakh₹53.6 cr3.05%
ALKEMAlkem Laboratories Limited Healthcare1.05 lakh₹53.6 cr3.05%
MANKINDMankind Pharma Limited Healthcare1.97 lakh₹49.1 cr2.79%
IPCALABIPCA Laboratories Limited Healthcare2.41 lakh₹46.5 cr2.65%
GLANDGland Pharma Limited Healthcare1.38 lakh₹42.8 cr2.44%
BIOCONBiocon Limited Healthcare12.10 lakh₹42.6 cr2.42%
SAILIFESai Life Sciences Limited Healthcare2.40 lakh₹37.4 cr2.13%
AJANTPHARMAjanta Pharma Limited Healthcare79,248₹27.8 cr1.58%
WOCKPHARMAWockhardt Limited Healthcare1.43 lakh₹27.3 cr1.55%
PPLPHARMAPiramal Pharma Limited Healthcare10.79 lakh₹25.8 cr1.47%
ABBOTINDIAAbbott India Limited Healthcare9,058₹23.2 cr1.32%
Show all 20 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: Nippon India Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202645.3%47.1%7.6%0.0%Jun 2026
Sep 202646.3%46.1%7.5%0.0%Jun 2026
Aug 202647.8%45.0%7.1%0.0%Jun 2026
Jul 202647.6%45.5%6.7%0.0%Jun 2026
Jun 202653.4%37.9%8.6%0.0%Dec 2025
May 202653.9%37.5%8.5%0.0%Dec 2025
Apr 202655.6%36.9%7.5%0.0%Dec 2025
Mar 202655.6%37.0%7.4%0.0%Dec 2025
Feb 202655.4%36.8%7.7%0.0%Dec 2025
Jan 202654.9%37.1%7.9%0.0%Dec 2025
Dec 202568.4%25.3%6.2%0.0%Jun 2025
Nov 202569.2%24.8%6.0%0.0%Jun 2025
Sources: Nippon India Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months10.4%Oct 2025 to Oct 2026 · bought ₹576 cr, sold ₹143 cr
MonthBoughtSoldTurnover
Oct 2026₹0.00 cr₹24.7 cr0.0%
Sep 2026₹25.4 cr₹0.49 cr0.0%
Aug 2026₹30.0 cr₹0.00 cr0.0%
Jul 2026₹65.2 cr₹72.0 cr3.9%
Jun 2026₹0.00 cr₹12.3 cr0.0%
May 2026₹151 cr₹0.00 cr0.0%
Apr 2026₹50.5 cr₹0.00 cr0.0%
Mar 2026₹223 cr₹0.00 cr0.0%
Feb 2026₹0.00 cr₹6.5 cr0.0%
Jan 2026₹26.4 cr₹0.00 cr0.0%
Dec 2025₹4.6 cr₹0.06 cr0.0%
Nov 2025₹0.00 cr₹26.8 cr0.0%
Source: Nippon India Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI Nifty Pharma TRI
1 year—+25.28 %+25.59 %
3 years—+21.97 %+22.28 %
5 years—+16.60 %+16.87 %
Since launch—+14.02 %—

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "Nippon India Nifty Pharma ETF"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

Nippon India Nifty Pharma ETF - Direct Plan: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+25.57 % in total 20 Nov 2025 · NAV ₹23.242420 Nov 2026 · NAV ₹29.1863
3 years+22.02 % a year, compounded 20 Nov 2023 · NAV ₹16.054520 Nov 2026 · NAV ₹29.1863
5 years+16.60 % a year, compounded 18 Nov 2021 · NAV ₹13.523120 Nov 2026 · NAV ₹29.1863
Since first NAV+14.02 % a year, compounded 6 Jul 2021 · NAV ₹14.409820 Nov 2026 · NAV ₹29.1863

Source: AMFI NAV files (plan code 149008). How to read Report a wrong number

Tracking error and tracking difference

index fund / ETF · as published by AMFI
Tracking error, direct plan

As published by AMFI, 19 Nov 2026.

Source: AMFI

—19 Nov 2026
Tracking error, regular plan+0.02 %19 Nov 2026
Tracking difference, Oct 2026Direct planRegular plan
1 year—−0.30 %
3 years—−0.32 %
5 years—−0.27 %
Since launch—−0.28 %

As AMFI publishes them against Nifty Pharma TRI. Source: AMFI tracking error and tracking difference. How to read

IDCW (dividend) history

0 declarations · as of 2 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Rolling returns, Nippon India Nifty Pharma ETF - Direct Plan

weekly NAVs · Source: AMFI
WindowLowestMedianHighestWindows above zero
1 year in total −13.34 % 9 Sep 2021 to 16 Sep 2022+13.73 % 24 Jun 2022 to 30 Jun 2023+63.77 % 3 Mar 2023 to 7 Mar 2024 73 % of 226 windows ending 15 Jul 2022 to 20 Nov 2026
3 years a year, compounded +12.36 % 16 Jul 2021 to 19 Jul 2024+20.37 % 18 Aug 2023 to 21 Aug 2026+27.03 % 19 May 2023 to 22 May 2026 100 % of 124 windows ending 12 Jul 2024 to 20 Nov 2026

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 24 Nov 2023 to 20 Nov 2026, 156 weekly changes.

Source: AMFI

14.97 %156 weeks to 20 Nov 2026
Largest fall from a high

High 14 Oct 2021, low 17 Mar 2023; back at the high 28 Jul 2023.

Weekly NAVs since 9 Jul 2021. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−20.00 %low 17 Mar 2023

Past performance may not be sustained in future.

52-week high NAV

Highest and lowest of 249 daily NAVs, 20 Nov 2025 to 20 Nov 2026, Nippon India Nifty Pharma ETF - Direct Plan.

Source: AMFI

₹29.70619 Nov 2026
52-week low NAV₹22.05291 Feb 2026

Calendar-year returns, Nippon India Nifty Pharma ETF - Direct Plan

NAV to NAV · Source: AMFI
YearReturnFromTo
2025−2.46 % 31 Dec 2024 · NAV ₹23.860131 Dec 2025 · NAV ₹23.2737
2024+39.59 % 29 Dec 2023 · NAV ₹17.093031 Dec 2024 · NAV ₹23.8601
2023+34.44 % 30 Dec 2022 · NAV ₹12.713829 Dec 2023 · NAV ₹17.0930
2022−10.86 % 31 Dec 2021 · NAV ₹14.262830 Dec 2022 · NAV ₹12.7138

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Monthly SIP of ₹10,000, Nippon India Nifty Pharma ETF - Direct Plan

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,41,252 20 Nov 2026 · NAV ₹29.1863+36.55 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Questions about Nippon India Nifty Pharma ETF

from the figures on this page

What are the top holdings of Nippon India Nifty Pharma ETF?

At Oct 2026 end, Nippon India Nifty Pharma ETF held 20 stocks (100.0% of the fund in equity). Largest: Sun Pharmaceutical Industries 18.61%, Divi's Laboratories 12.28%, Laurus Labs 9.26%, Dr. Reddy's Laboratories 8.15%, Cipla 7.67%; the top 10 make up 78.6%. Funds holding Sun Pharmaceutical Industries · Funds holding Divi's Laboratories · Funds holding Laurus Labs

What portfolio changes did Nippon India Nifty Pharma ETF make in Oct 2026?

Compared with Sep 2026, by share count: 0 new, 0 added, 20 trimmed, 0 exited. Largest by value: Sun Pharmaceutical Industries (trimmed), Divi's Laboratories (trimmed), Laurus Labs (trimmed), Dr. Reddy's Laboratories (trimmed).

Who manages Nippon India Nifty Pharma ETF?

AMFI's scheme summary document names Jitendra Tolani for Nippon India Nifty Pharma ETF (Nippon India Mutual Fund). Jitendra Tolani, fund manager portfolio

All schemes of Nippon India Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.